Nigeria’s ability to detect and contain infectious diseases is facing renewed scrutiny following the confirmation of an Ebola case linked to international travel, amid warnings that the virus could spread across national borders if surveillance and response systems fail to identify infections promptly.

The development has heightened concerns about the movement of people between African countries as health authorities work to establish the source of the infection and monitor individuals who may have been exposed.

The case involves a woman who travelled to Nigeria from Uganda and tested positive for the Bundibugyo strain of Ebola. Nigerian authorities have identified 44 contacts for monitoring, while investigations continue into the patient’s movements and possible exposure to others.

As of October 22, health officials had reported no evidence that the infection had spread into the wider Nigerian community. However, the case has reinforced the need for vigilance, particularly in a country with extensive domestic and international travel connections.

One of the major challenges in containing Ebola is that infected individuals may initially be treated for other illnesses when their symptoms resemble more common conditions. Delays in recognising the disease can complicate contact tracing and increase the possibility of exposure among healthcare workers, relatives and other people who come into contact with an infected person.

The wider outbreak, which began in the Democratic Republic of Congo in May, has spread to several countries, including Uganda and Kenya. The emergence of a case in Nigeria has extended the outbreak’s geographical reach and intensified concerns about the ability of national health systems to respond to infections that cross borders.

Africa CDC has called for stronger coordination among affected and at-risk countries, with surveillance, rapid diagnosis, contact tracing and preparedness among the priorities for limiting further transmission.

For Nigeria, the immediate task is to ensure that all identified contacts are properly monitored, additional potential exposures are investigated and suspected infections are assessed without delay. Clear public communication will also be important in preventing misinformation and encouraging people with concerning symptoms or relevant exposure histories to seek medical attention.

The response is particularly significant because the Bundibugyo strain has no approved vaccine or specific licensed treatment, making early detection and effective infection-control measures essential components of outbreak management.

Nigeria successfully contained an Ebola outbreak in 2014, demonstrating the importance of coordinated public health action. Authorities now face the challenge of applying those lessons to a different outbreak involving a strain for which medical countermeasures remain limited.

Although the confirmed case has not been shown to have triggered wider community transmission in Nigeria, the evolving regional situation underscores the need for sustained preparedness rather than a response limited to the immediate patient.

The effectiveness of Nigeria’s containment efforts will depend on how quickly health officials can identify possible infections, follow up exposed individuals and coordinate with regional partners as investigations progress.